The following video is part of our nationally syndicated Motley Fool Money radio show, in which host Chris Hill and advisors Ron Gross, James Early, and Seth Jayson discuss the week's business and investing news. In this segment, the guys examine the future of the prescription-drug industry and analyze the retail sector in search of stocks they like.
Chris Hill owns shares of Pfizer. The Motley Fool owns shares of Aeropostale. Motley Fool newsletter services have recommended buying shares of Pfizer and Cato. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
These 3 Healthcare Stock Dividends Could Soar If Trump Signs a Tax Reform Bill
A corporate tax rate reduction will raise some boats a lot higher than others.
5 Top Stocks for December
Rebalancing your portfolio for the new year? These stocks should be at the top of your buy list.
What Happened in the Stock Market Today
On a mixed day for the major benchmarks, CVS announced its acquisition of Aetna, and a report of a potential asset purchase by Disney made it the top performer in the Dow.